A review published in Annals of Allergy, Asthma & Immunology found that reactions to medications, though possible in patients with mast cells disorders such as systemic mastocytosis (SM), may not be as common as many believe.
“While drug-induced reactions, particularly anaphylaxis, are a major concern, recent data suggest that the overall prevalence of severe reactions is relatively low,” the authors said.
It’s fairly common for patients with SM to avoid taking medication out of fear of experiencing an adverse reaction. Although this is a valid concern, such behavior could prevent an individual from receiving the care that they need.
In their review, the authors explored several classes of drugs to determine which present the highest and lowest risks to patients with SM.
Read more about SM treatment and care
In one European registry, 8.7% of patients with mastocytosis reported a drug-induced reaction, with 12.5% of patients with advanced SM experienced a reaction. Another study found that 18.3% of individuals with a mast cell disorder reported a drug reaction, with 6.3% experiencing anaphylaxis.
Nonsteroidal anti-inflammatory drugs (NSAIDs), the class of drugs that includes ibuprofen and aspirin, emerged as the most common symptom trigger, followed by antibiotics. Perioperative drugs, which are given before, during and after surgical procedures, were the third most common trigger.
Local anesthesia and contrast media pose relatively low risks to patients with SM and other forms of mastocytosis, the authors said, though reactions are still possible.
Overall, these findings suggest that individuals with SM can continue to take medications that they have previously tolerated. More care should be taken in patients who are deemed high-risk, though. Antihistamines and corticosteroids may reduce the risk of experiencing a drug reaction, but the authors noted more research is needed to confirm this.
“Individualized assessment should be prioritized, relying on a detailed clinical history to guide decisions,” the authors wrote. “A history-driven, evidence-based approach allows the majority of patients with mast cell disorders to be treated effectively without unnecessary drug avoidance.”
Sign up here to get the latest news, perspectives, and information about SM sent directly to your inbox. Registration is free and only takes a minute.
